Marina Davidova
Managing Partner, co-founder @ Davidovs Venture Collective
Los Altos Hills, United States
Marina Davidova is a seed investor at Davidovs Venture Collective in Los Altos Hills focused on Artificial Intelligence and SaaS. I'm a founder and VC dedicated to building exceptional products and optimizing the world for happiness. I have the experience of being a two-time founder and a two-time mom, which has shaped my perspective on both business and life. I'm a lifelong learner, always seeking knowledge, and I proudly collect degrees (currently holding four). Iam the co-founder and GP of Davidovs Venture Collective (DVC), an early-stage VC backed by 99 engineers, founders, and angel investors and COO of Humanism.is, a platform for investments in future financial outputs of individuals.
- Total investments:
- 19
- Last investment:
- Lead investor:
- 11%
Last updated:
For AI agents: llms.txt
Industries Marina Davidova invests in
Stages Marina Davidova invests in
Countries Marina Davidova invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Artificial Intelligence 7 (37%)
- SaaS 5 (26%)
- Software 5 (26%)
- Information Technology 4 (21%)
- Analytics 3 (16%)
Stage
- Seed 8 (42%)
- Pre-Seed 5 (26%)
- Venture - Series Unknown 2 (11%)
- Angel 1 (5%)
- Series A 1 (5%)
Country
- United States 14 (74%)
- Canada 1 (5%)
- United Kingdom 1 (5%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Optic, an AI Drug Discovery company, is based in San Francisco. Our proprietary ligand-based and target-driven molecular search engine Bioptic.io identifies compounds by their activity-expressing fingerprints. It offers a novel approach to finding diverse candidate sets. In addition, we now also have an agentic AI platform for scientific andbusiness due diligence on drug assets. Our pipeline includes multiple pre-clinical stage programs, showcasing our commitment to practical, AI-driven solutions in cancer therapy. | $1M / Seed / Apr 10, 2025 | ||
| Run B2B content marketing with Autonomous AI agent that drives revenue | Pre-Seed / Jun 24, 2024 | ||
| Cambio Money is a financial services platform that aims to make financial solutions simple and accessible to individuals and businesses. It is dedicated to assisting people in saving, growing, and managing their money. It provides a variety of services, such as online payments, transfers, currency exchange, and budgeting tools. It aims to makefinancial management simpler and more efficient. The company also provides a secure platform to ensure the financial security. | $3M / Seed / Feb 13, 2024 | ||
| Essence is an employee benefits platform that empowers women and people with cycles to thrive in the workplace by optimizing well-being and productivity according to the menstrual cycle. | $600K / Seed / Feb 08, 2024 | ||
| JustPaid is a financial platform that helps startups control their spending and gives them financial oversight. | $500K / Pre-Seed / Apr 05, 2023 | ||
| GetGenAI is an AI platform that provides cloud communication tools that helps companies to check DEI-aligned content and mitigating risks. | Seed / Apr 01, 2023 | ||
| Mighty Health connects users to coaches to help them become healthier through exercise, nutrition, and wellness. | $7.6M / Series A / Jan 25, 2023 | ||
| No-code Data Science Assistant for Effective Leaders | Virtual Office for Immersive Culture Experience.Get numeric answers to the following questions using the data you already possess: - How to increase the performance and profitability of my teams / departments? - What attrition can I expect and what to do about it? (especially in light ofthe Great Resignation) - What is the true sentiment across the organization? - Are people actually engaged when in video conference calls? - How psychologically safe do people feel in my organization?Backed by: Venture Capital (Altair Capital) | Techstars 2020 | Enterprise Ireland | senior tech leaders at Google, Salesforce, LinkedIn, Facebook, Cisco, Juniper Networks, Uber, Dropbox, DocuSign, and growing.Let's change how work works! | Pre-Seed / Dec 09, 2022 | ||
| Meet people to have real-life experiences and have fun doing good | Venture - Series Unknown / Oct 12, 2022 | ||
| Optic, an AI Drug Discovery company, is based in San Francisco. Our proprietary ligand-based and target-driven molecular search engine Bioptic.io identifies compounds by their activity-expressing fingerprints. It offers a novel approach to finding diverse candidate sets. In addition, we now also have an agentic AI platform for scientific andbusiness due diligence on drug assets. Our pipeline includes multiple pre-clinical stage programs, showcasing our commitment to practical, AI-driven solutions in cancer therapy. | $11M / Seed / Jul 20, 2022 | ||
| See all 19 investments → | |||
Co-Investors
Davidovs Venture Collective is a VC firm based on a community of 99+ founders (including 4 active unicorn founders), operators, and angel investors. They are engineers with a lot of experience running startups and being value-added investors. DVC invests small entry checks from the rolling fund and follows up with bigger sums along the way. DVCpools together its collective network, expertise, and resources to help its portfolio companies. DVC's investment focus is quite broad, but DVC prefers partnering with experienced and repeat founders.
Davidovs Venture Collective Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Charles Ferguson
General Partner
|
|||
|
Marina Davidova
Managing Partner, co-founder
|
|||
Nick Davidov
Partner, co-founder
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Marina Davidova invest in?
Marina Davidova invests primarily in Artificial Intelligence, SaaS and Software startups, most often at Seed and Pre-Seed stage. Most of the 19 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Marina Davidova?
Public channels for Marina Davidova include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Marina Davidova last invest?
The most recent investment recorded for Marina Davidova closed in Apr 2025. Shizune tracks 19 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
